Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001615219-24-000038
Filing Date
2024-04-22
Accepted
2024-04-22 17:00:20
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A flks-20231231.htm   iXBRL 10-K/A 427735
2 EX-31.3 slrx20231231ex-313for10xka.htm EX-31.3 4622
3 EX-31.4 slrx12312023-314expfocerti.htm EX-31.4 4674
  Complete submission text file 0001615219-24-000038.txt   679777

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20231231.xsd EX-101.SCH 1926
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20231231_lab.xml EX-101.LAB 34496
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20231231_pre.xml EX-101.PRE 20084
18 EXTRACTED XBRL INSTANCE DOCUMENT flks-20231231_htm.xml XML 5031
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36812 | Film No.: 24861868
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)